公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines | WEI-WU CHEN ; DWANG-YING CHANG ; Huang S.-M.; CHING-HUNG LIN ; CHIUN HSU ; Lin M.-H.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; ANN-LII CHENG | Breast | 4 | 5 | |
2020 | Genomic-guided precision therapy for soft tissue sarcoma | Chen H.-W.; WEI-WU CHEN | ESMO Open | 5 | 3 | |
2015 | High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country | CHING-HUNG LIN ; Shen C.-Y.; JIH-HSIANG LEE ; CHIUN-SHENG HUANG ; CHIH-HSIN YANG ; WEN-HUNG KUO ; DWANG-YING CHANG ; Hsiung C.-N.; KUAN-TING KUO ; WEI-WU CHEN ; I-CHUN CHEN ; Wu P.-F.; SUNG-HSIN KUO ; Chen C.-J.; YEN-SHEN LU ; ANN-LII CHENG | PLoS ONE | 10 | 6 | |
2018 | Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer | BANG-BIN CHEN ; YEN-SHEN LU ; CHIH-WEI YU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | European Radiology | 9 | 9 | |
2012 | The impact of diabetes mellitus on prognosis of early breast cancer in Asia | WEI-WU CHEN ; YU-YUN SHAO ; Shau W.-Y.; ZHONG-ZHE LIN ; YEN-SHEN LU ; Chen H.-M.; Kuo R.N.C.; ANN-LII CHENG ; Lai M.-S. | Oncologist | 36 | 34 | |
2018 | Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer | Pezo R.C.; WEI-WU CHEN ; Berman H.K.; Mulligan A.M.; Razak A.A.; Siu L.L.; Cescon D.W.; Amir E.; Elser C.; Warr D.G.; Sridhar S.S.; Yu C.; Wang L.; Stockley T.L.; Kamel-Reid S.; Bedard P.L. | Breast Cancer Research and Treatment | 20 | 20 | |
2022 | Malignant granular cell tumour at the interventricular septum | Lou, Weng-Kin; HENG-WEN CHOU ; WEI-WU CHEN ; CHE-YU HSU ; JENG-WEI CHEN | Interactive cardiovascular and thoracic surgery | 0 | 0 | |
2018 | Managing the adverse effects related to immune checkpoint inhibitors | Kuo H.-H.; WEI-WU CHEN | Journal of Nursing | 3 | 0 | |
2016 | New hope for HER2-positive metastatic breast cancer treatment: Trastuzumab emtansine (T-DM1) from the perspective of nursing care | Kuo H.-H.; WEI-WU CHEN | Journal of Nursing | 2 | 0 | |
2023 | New targeted treatments for advanced sarcomas | CHIA-CHEN LI ; WEI-WU CHEN | Current opinion in oncology | 1 | 0 | |
2018 | Next frontiers in systemic therapy for soft tissue sarcoma | Yen C.-C.; WEI-WU CHEN | Chinese Clinical Oncology | 12 | 0 | |
2014 | No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen | WEI-WU CHEN ; Chen H.-M.; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; Lai M.-S.; YEN-SHEN LU | Breast Cancer Research and Treatment | 10 | 8 | |
2020 | Optimal clinical management and the molecular biology of angiosarcomas | WEI-WU CHEN ; Burns J.; Jones R.L.; Huang P.H. | Cancers | 15 | 16 | |
2013 | Personalized medicine for metastatic breast cancer | WEI-WU CHEN ; Bedard P.L. | Current Opinion in Oncology | 7 | 6 | |
2020 | A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors | JIH-HSIANG LEE ; WEI-WU CHEN ; CHIH-HUNG HSU ; Yen Y.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; CHIA-CHI LIN | Investigational New Drugs | 38 | 36 | |
2018 | A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer | WEI-WU CHEN ; Yeh D.-C.; Chao T.-Y.; CHING-HUNG LIN ; Chow L.W.-C.; DWANG-YING CHANG ; Hsieh Y.-Y.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU ; Taiwan Breast Cancer Consortium | Japanese Journal of Clinical Oncology | 4 | 3 | |
2015 | A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis | Wu P.-F.; CHING-HUNG LIN ; CHING-HUA KUO ; WEI-WU CHEN ; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU | BMC Cancer | 48 | 36 | |
2016 | A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer | BANG-BIN CHEN ; YEN-SHEN LU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wu P.-F.; CHAO-YU HSU ; CHIH-WEI YU ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | BMC Cancer | 20 | 17 | |
2023 | Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer | WEI-WU CHEN ; Hsiao, Wen; Dai, Ming-Shen; CHING-HUNG LIN ; DWANG-YING CHANG ; I-CHUN CHEN ; MING-YANG WANG ; Chang, Shu-Han; Huang, Shu-Min; ANN-LII CHENG ; Wu, Ko-Wen; Tan, Kien Thiam; YEN-SHEN LU | Breast cancer research and treatment | 0 | 0 | |
2019 | Primary cardiac sarcomas: A multi-national retrospective review | WEI-WU CHEN ; Loong H.H.; Srikanthan A.; Zer A.; Barua R.; Butany J.; Cusimano R.J.; Liang Y.-C.; Chang C.-H.; Iakobishvili Z.; Razak A.R.A.; Lewin J. | Cancer Medicine | 32 | 25 | |